Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 23, 2020
Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in JapanMichiko Kida, Kensuke Usuki, Naoyuki Uchida, et al.
Annals of Hematology|May 1, 2023
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogeneticsSatoshi Yamasaki, Shohei Mizuno, Makoto Iwasaki, et al.
Leukemia|December 21, 2023
Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remissionMasamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, et al.
American Journal of Hematology|May 23, 2025
Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First TransplantationKazuki Yoshimura, Hideki Nakasone, Masaharu Tamaki, et al.
British Journal of Haematology|October 19, 2023
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantationYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
Transplantation and Cellular Therapy|April 13, 2026
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemiaYasuyuki Arai, Marie Ohbiki, Mio Kurata, et al.
Cytotherapy|December 18, 2023
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular TherapyHiromi Hayashi, Makoto Iwasaki, Hideki Nakasone, et al.
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Transplantation and Cellular Therapy|July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program RegistryJunya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
British Journal of Haematology|April 6, 2026
Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide studyHidehiro Itonaga, Yasushi Miyazaki, Noriaki Tachi, et al.
Pageof 16